Evidence reviews
The following documents contain the evidence that was used to develop the 2022 recommendations:
- A: Service delivery
- B: Treatment of a new episode of depression
- C: Preventing relapse
- D: Further-line treatment
- E: Chronic depression
- F: Depression with coexisting personality disorder
- G: Psychotic depression
- H: Access to services
- I: Patient Choice
Evidence review supplements
- A1: Clinical evidence tables for review question 1.1
- A2: Clinical evidence tables for review question 1.2
- B1: Clinical evidence tables for review questions 2.1-2.2
- B2: Forest plots for treatment of a new episode of less severe depression
- B3: Forest plots for first-line treatment of more severe depression
- B4: Pairwise and NMA comparisons for review questions 2.1-2.2
- C1: Clinical evidence tables for review question 2.3
- D1: Clinical evidence tables for review question 2.4-2.5
- E1: Clinical evidence tables for review question 2.6
- F1: Clinical evidence tables for review question 2.7
- G1: Clinical evidence tables for review question 2.8
- H1: Clinical evidence tables for review question 3.0
- I1: Clinical evidence tables for review question 4.0
Evidence for the 2009 and 2021 recommendations can be found in the 2009 full guideline on the treatment and management of depression in adults, and supporting appendices:
- Full guideline - October 2009
- Appendix 15: Evidence tables for economic studies
- Appendix 16a: Clinical evidence profiles for service delivery
- Appendix 16b: Clinical evidence profiles for psychological and psychological interventions
- Appendix 16c: Clinical evidence profiles for pharmacological and physical interventions
- Appendix 16d: Clinical evidence profiles for the management of subthreshold depressive symptoms
- Appendix 17a: Clinical studies characteristics tables – service delivery
- Appendix 17b: Clinical studies characteristics tables – psychological and psychosocial interventions
- Appendix 17c: Clinical studies characteristics tables – pharmacological and physical interventions
- Appendix 17d: Clinical studies characteristics tables – management of subthreshold depressive symptoms
- Appendix 18: References to studies from the previous guideline
- Appendix 19a: Clinical evidence forest plots for service delivery
- Appendix 19b: Psychological and psychosocial clinical evidence forest plots
- Appendix 19c: Clinical evidence forest plots for pharmacology and other physical treatments
- Appendix 19d: Clinical evidence forest plots for the management of subthreshold depressive symptoms
- Appendix 20: Case identification included and excluded studies
- Appendix 21: Methods used to develop this guideline
Other supporting evidence
This page was last updated: